109 related articles for article (PubMed ID: 21602725)
1. Use of positron emission tomography in the evaluation of diffuse intrinsic brainstem gliomas in children.
Rosenfeld A; Etzl M; Bandy D; Carpenteri D; Gieseking A; Dvorchik I; Kaplan A
J Pediatr Hematol Oncol; 2011 Jul; 33(5):369-73. PubMed ID: 21602725
[TBL] [Abstract][Full Text] [Related]
2. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas.
Li DL; Xu YK; Wang QS; Wu HB; Li HS
Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472
[TBL] [Abstract][Full Text] [Related]
3. Correlation of
Zukotynski KA; Vajapeyam S; Fahey FH; Kocak M; Brown D; Ricci KI; Onar-Thomas A; Fouladi M; Poussaint TY
J Nucl Med; 2017 Aug; 58(8):1264-1269. PubMed ID: 28360212
[TBL] [Abstract][Full Text] [Related]
4. Results of positron emission tomography guidance and reassessment of the utility of and indications for stereotactic biopsy in children with infiltrative brainstem tumors.
Pirotte BJ; Lubansu A; Massager N; Wikler D; Goldman S; Levivier M
J Neurosurg; 2007 Nov; 107(5 Suppl):392-9. PubMed ID: 18459902
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of 18F-FDG PET and MRI associations in pediatric diffuse intrinsic brain stem glioma: a report from the Pediatric Brain Tumor Consortium.
Zukotynski KA; Fahey FH; Kocak M; Alavi A; Wong TZ; Treves ST; Shulkin BL; Haas-Kogan DA; Geyer JR; Vajapeyam S; Boyett JM; Kun LE; Poussaint TY
J Nucl Med; 2011 Feb; 52(2):188-95. PubMed ID: 21233173
[TBL] [Abstract][Full Text] [Related]
6. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
[TBL] [Abstract][Full Text] [Related]
7. Can multiparametric MRI and FDG-PET predict outcome in diffuse brainstem glioma? A report from a prospective phase-II study.
Goda JS; Dutta D; Raut N; Juvekar SL; Purandare N; Rangarajan V; Arora B; Gupta T; Kurkure P; Jalali R
Pediatr Neurosurg; 2013; 49(5):274-81. PubMed ID: 25277867
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of
Tinkle CL; Duncan EC; Doubrovin M; Han Y; Li Y; Kim H; Broniscer A; Snyder SE; Merchant TE; Shulkin BL
J Nucl Med; 2019 Mar; 60(3):312-319. PubMed ID: 30072503
[TBL] [Abstract][Full Text] [Related]
9. [Combined use of positron emission tomography with (18)F-fluorodeoxyglucose and (11)C-methionine for preoperative evaluation of gliomas].
Yamaguchi S; Terasaka S; Kobayashi H; Narita T; Hirata K; Shiga S; Usui R; Tanaka S; Kubota K; Murata J; Asaoka K
No Shinkei Geka; 2010 Jul; 38(7):621-8. PubMed ID: 20628188
[TBL] [Abstract][Full Text] [Related]
10. ¹⁸F-fluorodeoxyglucose and ¹¹C-methionine positron emission tomography in relation to methyl-guanine methyltransferase promoter methylation in high-grade gliomas.
Choi H; Bang JI; Cheon GJ; Kim YH; Park CK; Park SH; Kang KW; Chung JK; Kim EE; Lee DS
Nucl Med Commun; 2015 Mar; 36(3):211-8. PubMed ID: 25340951
[TBL] [Abstract][Full Text] [Related]
11. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.
Kaschten B; Stevenaert A; Sadzot B; Deprez M; Degueldre C; Del Fiore G; Luxen A; Reznik M
J Nucl Med; 1998 May; 39(5):778-85. PubMed ID: 9591574
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.
Pirotte B; Goldman S; Massager N; David P; Wikler D; Vandesteene A; Salmon I; Brotchi J; Levivier M
J Nucl Med; 2004 Aug; 45(8):1293-8. PubMed ID: 15299051
[TBL] [Abstract][Full Text] [Related]
13. Indolent dorsal midbrain tumor: new findings based on positron emission tomography.
Yamaguchi S; Terasaka S; Kobayashi H; Shiga T; Usui R; Hirata K; Kubota K; Murata J; Iwasaki Y
J Neurosurg Pediatr; 2009 Apr; 3(4):270-5. PubMed ID: 19338404
[TBL] [Abstract][Full Text] [Related]
14. 11C-methionine PET for grading and prognostication in gliomas: a comparison study with 18F-FDG PET and contrast enhancement on MRI.
Singhal T; Narayanan TK; Jacobs MP; Bal C; Mantil JC
J Nucl Med; 2012 Nov; 53(11):1709-15. PubMed ID: 23055534
[TBL] [Abstract][Full Text] [Related]
15. Molecular Drug Imaging:
Jansen MH; Veldhuijzen van Zanten SEM; van Vuurden DG; Huisman MC; Vugts DJ; Hoekstra OS; van Dongen GA; Kaspers GL
J Nucl Med; 2017 May; 58(5):711-716. PubMed ID: 27765855
[TBL] [Abstract][Full Text] [Related]
16. Paediatric brain-stem gliomas: MRI, FDG-PET and histological grading correlation.
Kwon JW; Kim IO; Cheon JE; Kim WS; Moon SG; Kim TJ; Chi JG; Wang KC; Chung JK; Yeon KM
Pediatr Radiol; 2006 Sep; 36(9):959-64. PubMed ID: 16847598
[TBL] [Abstract][Full Text] [Related]
17. Malignant brainstem tumors in children, excluding diffuse intrinsic pontine gliomas.
Klimo P; Nesvick CL; Broniscer A; Orr BA; Choudhri AF
J Neurosurg Pediatr; 2016 Jan; 17(1):57-65. PubMed ID: 26474099
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas.
Kumar R; Xiu Y; Potenta S; Mavi A; Zhuang H; Yu JQ; Dhurairaj T; Dadparvar S; Alavi A
J Nucl Med; 2004 Nov; 45(11):1796-803. PubMed ID: 15534046
[TBL] [Abstract][Full Text] [Related]
19. Imaging of adult brainstem gliomas.
Purohit B; Kamli AA; Kollias SS
Eur J Radiol; 2015 Apr; 84(4):709-20. PubMed ID: 25641008
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of focal cortical dysplasia and mixed neuronal and glial tumors in pediatric epilepsy patients using 18F-FDG and 11C-methionine pet.
Phi JH; Paeng JC; Lee HS; Wang KC; Cho BK; Lee JY; Park SH; Lee J; Lee DS; Kim SK
J Nucl Med; 2010 May; 51(5):728-34. PubMed ID: 20395328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
